Revelation Biosciences, Inc. (REVBW) SEC Filings — 2024
25 SEC filings for Revelation Biosciences, Inc. (REVBW) in 2024.
Filings
- Revelation Biosciences Files Definitive Proxy Statement — DEF 14A · Dec 16, 2024
- Revelation Biosciences Files 8-K on Warrants — 8-K · Dec 12, 2024
- Revelation Biosciences Files 8-K: Material Agreement & Equity Changes — 8-K · Dec 6, 2024
- Revelation Biosciences Q3 2024 Update: Net Loss and Stock Activity — 10-Q · Nov 8, 2024
- Revelation Biosciences Faces Delisting Concerns — 8-K · Oct 21, 2024
- Revelation Biosciences Files 8-K, Details Financials — 8-K · Sep 27, 2024
- Revelation Biosciences Files 2023 10-K Amendment — 10-K/A · Sep 23, 2024
- Revelation Biosciences Enters Material Agreement, Reports Equity Sales — 8-K · Aug 26, 2024
- Revelation Biosciences Faces Delisting Concerns — 8-K · Aug 19, 2024
- Revelation Biosciences Files Q2 10-Q with Warrant Details — 10-Q · Aug 9, 2024
- Revelation Biosciences Files 8-K — 8-K · Aug 2, 2024
- Revelation Biosciences Files 8-K — 8-K · Jun 24, 2024
- Revelation Biosciences Files 8-K — 8-K · May 16, 2024
- Revelation Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
- Revelation Biosciences Announces 2024 Annual Meeting of Stockholders on May 15 — DEF 14A · Apr 16, 2024
- Revelation Biosciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 22, 2024
- Revelation Biosciences Files 8-K — 8-K · Mar 12, 2024
- Revelation Biosciences, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Revelation Biosciences Issues Warrants Exercisable at $12,075/Share — 8-K · Feb 8, 2024
- Revelation Biosciences, Inc. Files Amendment No. 2 to S-1 Registration Statement — S-1/A · Jan 30, 2024
- Revelation Biosciences Confirms Common Stock & Warrant Details — 8-K · Jan 30, 2024
- Revelation Biosciences, Inc. Files Amendment No. 1 to S-1 Registration Statement — S-1/A · Jan 29, 2024
- Revelation Biosciences Warrants Diluted 35-to-1; Exercise Price $40.25 — 8-K · Jan 23, 2024
- REVELATION BIOSCIENCES Files 8-K on Shareholder Vote Matters — 8-K · Jan 22, 2024
- Sabby Volatility Fund Discloses 403,233 Share Stake in Revelation Biosciences — SC 13G · Jan 3, 2024